摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

17α-ethynyl-17β-hydroxy-5-androsten-3-one ethylene ketal | 50407-76-6

中文名称
——
中文别名
——
英文名称
17α-ethynyl-17β-hydroxy-5-androsten-3-one ethylene ketal
英文别名
3,3-ethylenedioxy-17α-ethynylandrost-5-en-17β-ol;3,3-ethanediyldioxy-17βH-pregn-5-en-20-yn-17-ol;3,3-Aethandiyldioxy-17βH-pregn-5-en-20-in-17-ol;17α-ethynyl-3,3-ethylenedioxy-5-androsten-17β-ol;3,3-ethylenedioxy-17β-hydroxy-17α-ethinylandrost-5-ene;3,3-Ethylenedioxy-17beta-hydroxy-17alpha-ethinylandrost-5-ene;(8'R,9'S,10'R,13'S,14'S,17'R)-17'-ethynyl-10',13'-dimethylspiro[1,3-dioxolane-2,3'-2,4,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene]-17'-ol
17α-ethynyl-17β-hydroxy-5-androsten-3-one ethylene ketal化学式
CAS
50407-76-6
化学式
C23H32O3
mdl
——
分子量
356.505
InChiKey
BWEWWHQUVVQNTN-GUCLMQHLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    258-259 °C
  • 沸点:
    471.2±45.0 °C(Predicted)
  • 密度:
    1.17±0.1 g/cm3(Predicted)
  • LogP:
    3.8 at 25℃ and pH5

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    26
  • 可旋转键数:
    1
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    38.7
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Process for the preparation of (Z)-17.alpha.-halovinyl steroids
    申请人:Schering Aktiengesellschaft
    公开号:US04885117A1
    公开(公告)日:1989-12-05
    (Z)-17.alpha.-halovinyl steroids of general Formula I ##STR1## wherein . . . . is a single bond or a double bond, V is a carbon-to-carbon bond or a methylene group, R.sub.1 is a hydrogen atom or a methyl group, X is a chlorine atom, a bromine atom or an iodine atom, and A symbolizes the remainder of the steroid molecule, are prepared by hydrogenating a 17.alpha.-haloethynyl steroid of formula II with diimide. ##STR2## wherein . . . , V, R.sub.1, X and A have the meanings given above. The compounds of Formula I include both known and novel compounds, all of which are pharmacologically active.
    通式I中的(Z)-17.alpha.-卤乙烯固醇 ##STR1## 其中...是单键或双键,V是碳与碳之间的键或亚甲基基团,R.sub.1是氢原子或甲基基团,X是原子、溴原子碘原子,而A代表类固醇分子的其余部分。这些化合物通过用双亚胺氢化17.alpha.-卤乙炔固醇II而制备得到。 ##STR2## 其中...,V,R.sub.1,X和A具有上述给定的含义。通式I的化合物包括已知的和新颖的化合物,所有这些化合物都具有药理活性。
  • Process and intermediates to prepare17beta-hydroxy-7alpha-methyl-19-nor-17alpha-pregn -5(10)-en-20-yn-3-one
    申请人:Martynow Jacek
    公开号:US20060111332A1
    公开(公告)日:2006-05-25
    The present invention is a process for the preparation of 17β-hydroxy-7α-methyl-19-nor-17α-pregn-5(10)-en-20-yn-3-one (17α-ethynyl-17β-hydroxy-7α-methyl-5(10)-estren-3-one, tibolone) of formula 1, which comprises hydrolysis of 17α-ethynyl-17β-hydroxy-7α-methyl-5(10)-estrene 3,3 -cyclic ketals of formula 2, where groups R 1 , R 2 , R 3 and R 4 are hydrogen atoms or alkyl groups, or R 1 and R 3 , taken together with the carbon atoms within the dioxolane ring to which they are attached, form an alicyclic ring fused to the dioxolane ring, with R 2 and R 4 being hydrogen atoms, or R 1 and R 3 together with the carbon atoms to which they are attached form an aromatic ring fused to the dioxolane ring, where R 2 and R 4 , taken together, form a chemical bond within said aromatic ring. In addition, the present invention includes an intermediate, compound of formula 2 and two processes to prepare 17α-ethynyl-17β-hydroxy-7α-methyl-5(10)-estrene 3,3 -cyclic ketals of formula 2: (a) by contacting 17α-ethynyl-17β-hydroxy-7α-methyl-4-estren-3-one with vicinal diols in the presence of a protic acid, and (b) by contacting 7α-methyl-5(10)-estrene-17-one 3,3-cyclic ketals of formula 4, where R 1 -R 4 are defined as above, with metal acetylides, in inert solvents.
    本发明涉及一种制备17β-羟基-7α-甲基-19-去氢-17α-孕-5(10)-烯-20-炔-3-酮(17α-乙炔基-17β-羟基-7α-甲基-5(10)-雌甾-3-酮,替泼酮)的方法,其包括对式2的17α-乙炔基-17β-羟基-7α-甲基-5(10)-雌甾-3,3-环糊精酮进行解,其中基团R1、R2、R3和R4是氢原子或烷基,或者R1和R3与它们所附着的二氧兰环内的碳原子一起形成螺环并与二氧兰环融合,其中R2和R4是氢原子,或者R1和R3与它们所附着的碳原子一起形成与二氧兰环融合的芳香环,其中R2和R4一起在该芳香环内形成化学键。此外,本发明还包括一个中间体,化合物的式子为2,并且还包括两种制备式2的17α-乙炔基-17β-羟基-7α-甲基-5(10)-雌甾-3,3-环糊精酮的方法:(a)通过在质子酸存在下与邻二醇接触17α-乙炔基-17β-羟基-7α-甲基-4-雌甾-3-酮,和(b)通过在惰性溶剂中与乙炔基化合物接触式4的7α-甲基-5(10)-雌甾-17-酮3,3-环糊精酮,其中R1-R4的定义如上。
  • Spironolactone process
    申请人:The Upjohn Company
    公开号:US04211701A1
    公开(公告)日:1980-07-08
    Spironolactone (VIII) is produced from ethisterone (I) by formation of the lactone (IV), a halo lactone (VI) and a .DELTA.4,6-lactone (VII).
    Spironolactone(VIII)是通过形成内酯(IV),卤代内酯(VI)和.DELTA.4,6-内酯(VII)从乙烯雌酮(I)生产的。
  • Preparation of 17α-iodoethynylandrosta- and 17α-(2-iodoethenyl) androsta-4,6-dien-17β-ol-3-ones as active site-directed photoaffinity ligands for androgen-binding proteins
    作者:Pablo J. Diaz Cruz、N.Scott Mason、Benjamin J. Danzo、Howard E. Smith
    DOI:10.1016/0039-128x(92)90027-7
    日期:1992.11
    Unsaturated analogues of androst-4-en-17 beta-ol-3-one, each with a 17 alpha-iodoethynyl or 17 alpha-(2-iodoethenyl) substituent, were prepared, and their relative binding affinities (RBAs) for androgen-binding protein (ABP) were compared with those of 5 alpha-androstan-17 beta-ol-3-one, androst-4-en-17 beta-ol-3-one, androsta-4,6-dien-17 beta-ol-3-one, and androsta-1,4,6-trien-17 beta-ol-3-one. These binding studies indicate that the iodine[125I] analogues of 17 alpha-iodoethynyl and 17 alpha-[(E)-2-iodoethenyl] derivatives of androsta-4,6-dien-17 beta-ol-3-one and androsta-1,4,6-trien-17 beta-ol-3-one will have RBAs at least twice as great as that of 5 alpha-androstan-17 beta-ol-3-one. They can be prepared from 17 alpha-ethynylandrosta-4-en-17 beta-ol-3-one, the final synthetic step using N-[125I]iodosuccinimide, and are potential radioiodinated, active site-directed photoaffinity ligands for ABP and testosterone-binding globulin.
  • Cyclic ketals of 3-keto-17-hydroxy-17-ethynyl-cyclopentanoperhydrophenanthrenes, andmethod of preparing them
    申请人:SQUIBB &
    公开号:US02288854A1
    公开(公告)日:1942-07-07
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B